wegovy a glp 1 Novo's becomes first GLP-1 drug approved for MASH Oksana Aron, M.D., Medical Weight

Here's who is (and is not) an ideal candidate for medical weight loss:

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

The 44-year-old tennis champion said she feels even healthier than she did as a professional athlete.

Nevertheless, the overall drug exposure was not considered clinically significant

The Cravings Battler: Those fighting a daily battle against uncontrollable cravings, overeating, and endless hunger cues

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes &amp